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Naturally occurring forms of Vitamin E are metabolized to various carboxychromanols 
and conjugated carboxychromanols. Recent studies showed that vitamin E metabolites, 
especially the long-chain carboxychromanols are more bioactive than unmetabolized 
vitamin E forms. It is necessary to quantify vitamin E metabolites in biological 
environment. Here a simple and effective extraction method was developed to achieve 
extraction efficacy of more than 90% of various forms of vitamin E and metabolites with 
less than 10% inter- or intra-day variation. An LC-MS/MS assay was developed and 
optimized to acquire best sensitivity for the detection of vitamin E and metabolites. This 
method allows simultaneous detection of all carboxychromanols and sulfated 
carboxychromanols. Using the optimized extraction and LC-MS/MS analysis conditions, 
vitamin E metabolites in plasma or feces of animals fed with γT, γTE, δT or δTE-13' were 
analyzed. Results showed that, the major metabolites in the blood were conjugated γ-







CHAPTER 1. LITERATURE REVIEW 
1.1 Overview of Vitamin E 
Vitamin E is a required nutrient that is synthesized by photosynthetic plants and 
provides various health benefits to human (1). Vitamin E was identified as a fertility 
factor in 1922 by Evans and Bishop since vitamin E deficiency leads to fatal resorption. 
Therefore, vitamin E was named after the Greek word tokos, which stands for childbirth 
(2). There are eight naturally occurring isoforms in the vitamin E family, four tocopherols 
(α, β, γ and δT) and four tocotrienols (α, β, γ and δTE) (3). These isoforms differ in the 
methylation on their chromanol ring structures. Tocotrienols differ from tocopherols in 
the 3 double bonds on their 13-carbon side chain.  
 
Vitamin E is widely consumed in North American diet especially in plant seeds and oil. 
Dietary sources of vitamin E include olive oil, sunflower oil, almonds, peanuts, etc. 
Among all the vitamin E isoforms, γT is the major form being consumed in US diet (4). 
Once absorbed, vitamin E is metabolized in the liver and generates various conjugated 
and non-conjugated carboxychromanols. The terminal metabolite, 3’-carboxychromanol, 





excreted in urine while the unconjugated long chain metabolites were found excreted in 
feces. Unmetabolized vitamin E is also excreted in feces. αT is more extensively 
accumulated in body tissue than any of the other vitamin E forms (5,6,7). Thus between 










Figure 1.1. Structures of Naturally Occurring Vitamin E 
Tocopherols and tocotrienols have a chromanol ring and a 13-carbon side chain. 
Tocotrienols have 3 double bonds on the side chain while tocopherols have fully 
saturated side chain. Substitution on R1 and R2 positions on the chromanol ring 






The first investigation, also the most well-known biological activity of vitamin E was as 
an antioxidant. αT has been found to be an important lipophilic antioxidant that 
terminates the chain reaction of lipid peroxidation initiated by free radicals. In the early 
1980s, Burton et al studied αT’s antioxidant property both in vitro and in vivo. α-T was 
first found to inhibit lipid peroxidation induced by free radicals in rat liver microsomes 
by converting the free radicals into harmless hydroperoxide products thus removing the 
free radicals from the destructive propagative cycle of lipid peroxidation (9). In fact, 
compared with the commercial antioxidant, butylated hydroxytoluene (BHT), the 
antioxidant activity of α-T was proved to be approximately 200 times greater with a 
peroxyl radical. This suggests that αT is a very effective antioxidant. 
 
Since 1990, other biological functions of vitamin E have also been studied. For example, 
αT was found to dose dependently potentiate basal prostacyclin release, a potent 
vasodilator and platelet aggregation inhibitor, in rat heart and human umbilical vein 
endothelial cells (10,11,12). This study demonstrated that in addition to the antioxidant 
property, αT also exhibits non-antioxidant activities. Besides, α-T has been found to 
inhibit smooth muscle cell proliferation by inhibiting protein kinase C activity (13).  
 
In late 1990s, researchers attention was drawn to γT, the major dietary form of vitamin 
E. Studies found that the urinary excreted metabolite of γT, γ-CEHC, is a natriuretic 
factor. Interestingly, γ-CEHC also inhibits cyclooxygenase-2 (COX-2) catalyzed synthesis 





revealing the bioactivity of vitamin E metabolites (14). This finding led to the 
investigation of vitamin E metabolism to understand how it becomes the bioactive 
metabolite. 
 
1.2 Vitamin E Metabolism 
The metabolism of vitamin E has been studied ever since 1960s. However, the clear 
picture of the metabolic pathway weren't characterized until recently. The absorption 
and distribution of vitamin E has been studied since 1980s using deuterium-labeled αT 
(15). Pharmacokinetic samples from rats after uptake of deuterium-labeled αT were 
analyzed by GC-MS to elucidate the transport and distribution of vitamin E. The 
discovery of urinary excreted metabolites of δT, δ-CEHC enlighted the investigation of 
catabolism pathway of vitamin E (5). Studies revealed that human liver HepG2 cells 
actively metabolize γT into γ-CEHC and a 5'-carboxychromanol γT metabolite, 2,7,8-
trimethyl-2-(delta-carboxymethylbutyl)-6-hydroxychroman (γ-CMBHC), as identified by 
GC-MS/MS analysis of the extracted HepG2 cells cultured medium incubated with 50 
μM of γT for 48 h (16). It has also been reported that dietary intake of sesame seed or 
sesamin, a potent inhibitor of cytochrome P450 enzyme, elevated the concentration of 
γT in plasma, liver and lung of rats supplemented with high level of γT in the diet (17). 
Based on these evidences, a study by Parker et al in 2000 proved that the γT catabolism 
pathway is cytochrome P450 enzyme dependent and is inhibited by sesamin using 
HepG2 as the experiment model (18). The hepatic catabolism pathway of truncating the 





γT, 7'-, 9'-, 11'- and 13'-carboxychromanols were detected and identified by GC-MS 
analysis of HepG2 cell cultured media extracts. It was also elucidated that the 
discrimination of αT metabolism by γT is partially due to their different enzyme specific 
activity of CYP4F2, the isoform of cytochrome P450 enzyme responsible for the 
metabolism of vitamin E. This finding brought a new insight to the study of vitamin E 
metabolism. In 2007, Jiang et al. discovered a novel metabolism pathway of γT and δT in 
human lung epithelial A549 cells by HPLC-FL assay, electrospray and inductively coupled 
plasma mass spectrometry(19). These novel vitamin E metabolites were identified as 
sulfated long chain carboxychromanols. This finding provided evidence that sulfation 
occurs as part of the intracellular metabolism of vitamin E. Vitamin E metabolism is 
described in more detail in the sections below. 
 
1.2.1 Overview of Intestinal Absorption, Transport and Tissue Distribution of Vitamin E 
The absorption of vitamin E was studied in Caco-2 cells and in transgenic mice models. 
Dietary vitamin E is esterified by fatty acids and incorporated into micelles and 
hydrolyzed by pancreatic lipase. Once vitamin E is located in the GI lumen, it is absorbed 
in the middle of gastric intestinal tract, in the distal jejunum (20). Intestinal uptake of 
vitamin E is initiated by two types of apical membrane bound protein, scavenger 
receptor class B type 1 (SR-B1) and Niemann-Pick type C1-like 1 (NPC1L1). The major 
secretion route of intestinal absorbed vitamin E is through chylomicron whereas a 
smaller fraction is secreted via ATP-binding cassette A1 (ABCA1), both on the 





the lymphatic system to the peripheral tissues. The resulting chylomicron remnants are 
taken up by the liver where vitamin E is metabolized and excreted into the circulation 
(21).  
 
In hepatocytes, α-tocopherol transport protein (α-TTP) and ABCA1 preferentially binds 
with α-T and incorporates it into lipoproteins which facilitates its transport into 
peripheral tissues via the circulation (22,23). Other unbound vitamin E forms are 
catabolized in hepatocytes. Conjugated and unconjugated vitamin E metabolites 
generated in the intracellular catabolism are excreted through urine and bile, 
respectively (5,16). Vitamin E not utilized or metabolized in cell is also discarded via bile 







Figure 1.2. Intestinal Absorption of Vitamin E. 
Vitamin E uptake occurs at the apical membrane of the intestinal cells by the proteins 
NPC1L1 and SR-BI. After absorption, a small fraction of vitamin E is secreted by ABCA1 
on the basolateral side via an apolipoprotein AI pathway. The main fraction is secreted 







Figure 1.3. Transport and Tissue Distribution of αT 
Vitamin E secreted from intestine is packaged in chylomicron and taken up by liver. α-
TTP preferentially binds with αT and, with the assistance of ABCA1, incorporates them 
into lipoprotein which then transports αT into the circulation and distribute to 
peripheral tissue. Except for αT, large portions of other forms of vitamin E, such as γT, 
γTE and δT, are catabolized in hepatocytes through cytochrome P450 mediated 








Figure 1.4 Transport of γT, δT and TEs 
Except for αT, a majority of the vitamin E forms are metabolized by the cytochrome 
P450 enzyme mediated intracellular catabolism pathway in the liver. The metabolites 
generated from the metabolism pathway enters the circulation and the end product, 
CEHCs are excreted in urine and bile. Small portions of the unmetabolized non-α-forms 
of vitamin E are transported by α-TTP and incorporated in lipoproteins into the 







1.2.2 Intracellular Catabolism Pathway of Vitamin E 
Vitamin E has been found to be extensively metabolized in human lung epithelial cells 
and human hepatocytes (16,27). After vitamin E is taken up by the liver and transported 
into hepatocytes, it is translocated into endoplasmic reticulum and metabolized by 
cytochrome P450 enzyme mediated ω-hydroxylation, which forms 13’-
hydroxychromanol (13’-OH). This water-soluble product is then located into 
mitochondria and metabolized by 5 cycles of step-wise β-oxidation, which truncates 
vitamin E side-chain by 2-carbon moiety (18,28). Sulfation, parallel to β-oxidation, has 
been found to occur to the intermediate and terminal vitamin E metabolites by the 
effect of cytosolic sulfotransferase(19,29). These sulfated long chain metabolites of 
vitamin E were found in both cultured A549 human lung epithelial cells and plasma of 













Vitamin E metabolism is initiated by CYP4F2 mediated ω-hydroxylation and ω-oxidation 
in endoplasmic reticulum then followed by 5 cycles of β-oxidation in the mitochondria 
and peroxisome. Parallel to the β-oxidation, the carboxychromanols are sulfated by 
cytosolic sulfotransferase and generating sulfated metabolites. Whether the sulfated 









1.2.3 Regulation of Vitamin E Metabolism 
It's well known that there's difference of bioavailability among vitamin E forms. 
However the reason was not revealed until lately. Although being consumed in US diet 
in a much higher content compared to αT, the tissue retention of γT is relatively 
low(4).Another evidence of regulation of vitamin E metabolism is that γTE, the 
counterpart of γT with unsaturated side-chain, are much more extensively metabolized 
than γT in human liver HepG2 cells and lung epithelial A549 cells (30,31). This evidence 
suggests that vitamin E metabolism is tightly regulated. 
 
Up to now, only 1 study suggested different intestinal absorption between tocotrienols 
and tocopherols. The study by Abuasol et al in 2012 (32) compared the NPC1L1 
mediated intestinal uptake of γTE and αT in rats hepatoma cells. The NPC1L1 kinetic 
studies demonstrated higher Vmax value for αT compared with γTE. These findings 
suggest that intestinal absorption mediated by NPC1L1 favors αT compared to γTE. 
 
Vitamin E metabolism is mainly regulated by the intracellular metabolism and the 
hepatic excretion. So far, there are three important regulators that have been identified 
to exhibit different biological activity or affinity towards different forms of vitamin E.  
 
Firstly, α-TTP, the protein that is responsible for the hepatic secretion of vitamin E to the 
circulation and peripheral tissue, has different binding affinity towards vitamin E 







investigate the structural characteristics of vitamin E analogs required for recognition by 
α-TTP. This study found that αT exhibits the highest ligand binding affinity (100%) and 
calculated the affinity of other vitamin E forms base on competition: βT, 38%; γT, 9%; δT, 
2%; αTE, 12% (33,34). This finding is in line with their tissue concentrations. Interestingly, 
in patients with deficiency of α-TTP, urinary excreted α-CEHC is at significantly higher 
level compared to healthy participants (35). The increase of αT degradation in α-TTP 
deficient patients suggests that α-TTP plays an important role in regulating the 
metabolism of αT.  
 
Secondly, the cytochrome P450 enzyme mediating the ω-hydroxylation in intracellular 
catabolism, CYP4F2, exhibits different activity to γT and γTE(36). In human hepatocyte 
HepG2 cells and human liver microsomes expressing recombinant cytochrome P450 
enzyme (isoform CYP4F2) incubated with vitamin E isoforms, both systems have shown 
to exhibit substrate preference for γTE over γT. Enzyme kinetic study further proved 
that CYP4F2, the cytochrome P450 enzyme involved in ω-hydroxylation of the methyl 
group on the phytyl chain, has higher binding affinity and enzyme specific activity 
towards γTE than γT. The preferential ligand binding and enzyme specific activity of 
CYP4F2 towards tocotrienols results in faster and more extensive hydroxylation of γTE 
than γT. This allows the faster metabolism of γTE than γT (36,37).  
 
The third regulator of intracellular catabolism is the cytosolic sulfotransferase. Following 







carboxychromanols are sulfated in the cytosol. SULT1, a family of human cytosolic 
sulfotransferases, are so far the only known enzyme mediating the sulfation reaction of 
tocopherols and their metabolites. Researchers found that in human lung epithelial cells 
incubated with vitamin E isoforms and 32S labeled sulfate, more 32S-Sulfate was 
generated in cells incubated with γ-T than α-T (29). This is confirmed by the enzyme 
kinetic study where SULT1 has 4 fold higher substrate preference and less than 3 fold 
higher enzyme specific activity for γ-T than α-T. However, SULT1’s binding affinity for 
tocotrienols has not been investigated yet. But it’s speculated that SULT1 has higher 
binding affinity for tocotrienols than tocopherols due to the fact that more sulfated 
metabolites are generated by γTE than γT(31). Combining the effect of these regulators 
in intracellular metabolism of vitamin E, among all the tocopherols, α-T is most 
preferentially bound by α-TTP and is mostly retained in body tissue rather than being 
metabolized while other forms of vitamin E are preferentially metabolized. Among these 
unbound forms of vitamin E, γTE is preferentially hydroxylated by CYP4F2 and then β-








1.3 Analysis Methods of Vitamin E Metabolites 
Quantitative analysis of vitamin E enhances our knowledge about the bioavailability and 
bioactivity of vitamin E. Since 1940s, researchers investigated analytical methods to 
quantify vitamin E. The earliest quantification method of vitamin E was by Quaife in 
1948 (38). Biological samples, including liver, heart and kidney were homogenized and 
extracted with organic solvents. Then the extracted samples were reacted with the 
diazotized o-dianisidine to couple with tocopherols and form colored compounds. 
Samples are then step-wise diluted and measured by the absorbance at 520 nm. He 
reported > 90% recovery rate of all the biological samples spiked with same 
concentration of tocopherols. This method had been the most accurate method up to 
this time. GLC and TLC had also been used to separate tocopherols, however the 
method has been reported with poor reproducibility(39). In 1970s, researchers used 
high speed liquid chromatography (HSLC) with reversed phase column to separate 
tocopherols and used a UV spectrometer to detect signal of tocopherols. This method 
proved to recover almost 100% of different forms of vitamin E.  
 
Gas chromatography-mass spectrometry (GC-MS) was another popular quantification 
method of vitamin E. However, GC is not capable of quantifying sulfated vitamin E 
metabolites due to the inertness of the conjugated phenolic group to chemical 
derivatization. HPLC-FL detection allowed detection of sulfated metabolites and has 
good sensitivity to the chromanol ring structure regardless of the length of side chain. 







E, metabolites could not be separated due to their similarity in polarity. LC-MS/MS 
becomes the optimum detection method for vitamin E and metabolites, especially in 
biological samples due to its ability to eliminate back ground interference and specificity 
upon each individual compound. The instrumentation of LC-MS/MS will be explained in 
the following section. 
 
1.4 Instrumentation of LC-ESI-MS 
MS/MS analysis specifies the triple quadrupole (QQQ) instrument to monitor specific 
precursor ion and product ion mass-to-charge ratio thus eliminates the background 
noise interference and creates a brighter signal for the analytes. Eluents from liquid 
chromatography are nebulized and the sample droplets are emitted into the ionization 
zone. Among different ionization methods, electrospray ionization have been shown to 
exhibit highest sensitivity for vitamin E metabolites. In the ESI zone, sample droplets are 
charged with a high voltage to electrode charges to ensure formation of ions. These ions 
then enter the mass spectrometer for analysis. QQQ consist of 3 sets of parallel rods. 
The first quadrupole (Q1) filters the m/z value of all the ions in the sample and allows 
selective ions to pass through and enter the second quadrupole (Q2). Q2 is a collision 
cell in which selective precursor ions are applied with designated collision energy and 
fragmented by collision induced dissociation. These fragmented ions then enter the 









Figure 1.6 Orthogonal Introduction and Electrospray Ionization 
Sample is ionized by the nebulizing spray with the addition of super heated nitrogen gas, 
which significantly improves the signal-to-noise ratio by hastening the drying of the ions 












Figure 1.7 Triple Quadrupole MS 
After ionization, ions are guided by the octopole to the triple-quadrupole where they 
are analyzed. Each quadrupole consists of four parallel rods. Ions arrived at the first 
quadrupole (Q1) are filtered and only selected ions are allowed to pass through. In the 
Q2, which is a collision cell, precursor ions are fragmented. The fragment ions formed in 
the collision cell are then sent to the Q3 for a second filtering stage. The triple 
quadrupole allows monitoring of multiple precursor to product ion transitions (40). 











Figure 1.8 Mass Spectrometer 
Ions generated by the ionization source are collected into the funnel (Q1). Ions with 
different mass-to-charge (m/z) ratio are analyzed on a moving belt where ions with 
designated precursor ion m/z value are allowed to pass through the opening on the belt 
and travel to the collision cell (Q2). Collision cell is actually a hexapole filled with 
nitrogen gas. Specified voltage is applied to the ions in the collision cell for 
fragmentation. The fragment ions are then scanned through the third quadrupole, all 
product ions (product ion scan MS/MS) or selective product ions (MRM) are passed 







QQQ instrument allows 3 types of sample analysis, total ion scan, product ion scan and 
multiple reaction monitoring (MRM) analysis.  
In the case of a total ion scan, also known as a full scan, only 1 quadrupole will be used 
to detect all the ions. In this case the sensitivity would be compromised compared to 
product ion scan or MRM since the filter will scan through all the ions instead of 
selected ions. 
In terms of product ion scan, Q1 and Q2 can be fixed to up to 4 precursor ion m/z and 4 
specific collision energy levels in total. Q3 will scan through all the fragment ions and 
result in a product ion scan MS/MS chromatogram. This process identifies fingerprint of 
the compounds and is commonly used to optimize the acquisition method that yields 
highest intensity of the product ion scan.  
The most sensitive and most commonly used analysis method of QQQ is MRM mode. In 
this case, both belts are fixed to allow specific precursor ions and product ions to pass 
through with designated collision energy. In order to quantify vitamin E metabolites in 
biological samples, the acquisition methods have been optimized by product ion scan 









CHAPTER 2. MATERIALS AND METHODS 
2.1 Chemicals and Reagents 
Reagents used in cell culture, like trypsin, and fetal bovine serum (FBS), were purchased 
from Invitrogen (Gland Island, NY). Cell medium, including McCoy’s 5A modified medium 
and Dulbecco’s modified eagle medium (DMEM) were purchased from American Type 
Culture Collection (ATCC company, Manassas, VA). Different forms of vitamin E, 
including γ-tocopherol and δ-tocopherol, 3-(4, 5-dimethylthiazol-2-yl)-2, DMSO and all 
other chemicals were purchased from Fluka and Sigma (St. Louis, MO). γ-tocotrienol was 
a gift from Klaus Kramer (BASF, Ludwigshafen, Germany). 
 
2.2 Cell Lines and Treatment 
Human lung epithelial A549cells (purchased from ATCC company, Manassas, VA), were 
used in this study(19). A549 cells were routinely grown in 75 cm2 culture flask containing 
fresh McCoy’s 5A medium supplemented with 10% FBS. The flasks were placed in 37oC, 
95% air and 5% CO2 humidified incubator, and the caps were loosened if not vented 
During experiments, cells were seeded in McCoy’s 5A medium containing 10% FBS in 
each well of the 6-well plates at a density of 1×106 cells/well. Cells became attached 







fresh DMEM containing 1% FBS and γTE 20 μM and incubated for 72h or δTE-13' at 10 
μM and incubated for 4, 8, 12, 16 or 24h. Medium was collected to analyze the 
metabolites. 
 
2.3 Preparation of Vitamin E Standard Solutions 
γ-Tocopherol, δ-tocopherol were dissolved in 100% ethanol as stock solutions at the 
concentration of 500 μM and stored at -20oC.γ-CEHC, α-CEHC, δTE-13' and δT-13' were 
dissolved in 100% ethanol as stock solutions at the concentration of 2.5mM and stored 
at -20oC. The stock solution was further diluted into 100μM with 100% ethanol. At the 
time of experiment, all standard solutions were protected from light by aluminum foil. 
 
2.4 Optimization and Validation of Extraction Method 
Various vitamin E standards, namely γ-CEHC, α-CEHC, α-CMBHC, δTE-13', δT-13', δT and 
γT were spiked into Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum 
(FBS) to mimic cell cultured medium samples or plasma samples, respectively, or 100% 
ethanol as the standard solution, to the final concentrations of 2 μM, 10 μM, 2 μM, 1 
μM, 0.4 μM,0.4 μM and 0.4 μM, respectively, to achieve proper detection by HPLC-
Fluorescence (HPLC-FL) assay. These vitamin E standards were extracted by the method 
described in section 2.5 and 2.6 and resuspended and analyzed by HPLC-FL. The 
recovery rate of vitamin from DMEM and FBS were calculated by comparing their 








2.5 Extraction of Vitamin E and Metabolites in Cell Cultured Medium 
The vitamin E metabolites, tocopherols and tocotrienols were extracted from the cell 
cultured media by mixing 100ul of cell culture media with 600ul of working methanol 
solution (contains 0.2mg/ml ascorbic acid) and 500ul hexane. After mixing and a brief 
centrifugation (10,000 rpm for 2 minutes), the hexane layer which contains tocopherols 
and tocotrienols and methanol layer that contains the vitamin E metabolites were 
collected separately. Butylated hydroxytoluene (BHT) solution (66mg/ml) was added to 
the hexane layer and mixed as an antioxidant of the tocopherols and tocotrienols. 
Another 400ul of working methanol was added to the protein residue to extract any 
remaining vitamin E metabolites. After vortex and centrifugation, the methanol layer 
was combined with the previous one. All organic layers were dried under N2 and stored 
in -20oC until use. 
 
2.6 Extraction of Vitamin E and Metabolites in Fetal Bovine Serum and Animal Plasma 
Samples 
The vitamin E metabolites, tocopherols and tocotrienols were extracted from the Fetal 
Bovine Serum (FBS)  or animal plasma samples by mixing 100ul of FBS sample or animal 
plasma samples with 600ul of working methanol solution (contains 0.2mg/ml ascorbic 
acid) and 1.2ml of hexane. After mixing and a brief centrifugation (13,200 rpm for 2 
minutes), the hexane layer which contains tocopherols and tocotrienols and methanol 
layer that contains the vitamin E metabolites were collected separately. BHT solution 







tocopherols and tocotrienols. Another 400ul of working methanol was added to the 
protein residue to extract any remaining vitamin E metabolites. After vortex and 
centrifugation, the methanol layer was combined with the previous one. All organic 









Figure 2.1 Method of Extraction of Vitamin E Standards in FBS 
Vitamin E standards spiked into FBS are extracted by methanol (6:1 v/v) and hexane 
(12:1 v/v). After 1 min of vigorous vortex and 2 min of centrifugation at 13,000 rpm, 
organic phases which contain vitamin E standards are collected. The residue was re-
extracted with methanol (4:1 v/v). The supernatant was combined with the previously 









2.7 Extraction of Vitamin E Metabolites in Animal Diet 
The vitamin E metabolites were extracted from the diet pellets fed to animals by 
dissolving around 150 mg of chopped animal diet in 1ml of working methanol solution 
(contains 0.2mg/ml ascorbic acid). After mixing, the diet sample is further homogenized 
with homogenizer and pestle for around 30 strokes. Put the sample on ice for 2 min and 
then isolate 350ul of supernatant to a new tube. Dry under N2 and store at -20 oC until 
analysis. 
 
2.8 Extraction of Vitamin E Metabolites in Animal Feces 
The vitamin E metabolites, tocopherols and tocotrienols were extracted from the animal 
feces by dispersing around 25 mg of animal feces in 200ul of working methanol solution 
(contains 0.2mg/ml ascorbic acid). The feces pellet was broken down to small pieces and 
then another 1.8 ml working methanol solution was added. The dispersion was 
homogenized with the pestle and the homogenizer for around 30 strokes until the 
particles are mostly broken down. After homogenization, put the sample on ice for 2 
min and then collect 1.8ml of supernatant to a new tube. Centrifuge at 10,000 rpm for 5 
min at 4oC and then transfer 1.4ml supernatant to a new tube. Dry under N2 and store at 









Figure 2.2 Method of Extraction of Vitamin E Metabolites in Animal Fecal Samples 
As described in section 2.8, animal fecal samples were weighed and homogenized under 
a homogenizer. Vitamin E metabolites were extracted by 2 ml of methanol. 1.8 ml of 
supernatant was collected after sitting on ice for 2 min. The dispersion was centrifuged 
at 10,000 rpm at 4 oC for 5 min and 1.4 ml of supernatant was collected to a new tube. 








2.9 Sulfatase Treatment of Vitamin E Metabolites 
100 μl of plasma or cell cultured medium sample was extracted by the method 
described in section 2.5 and 2.4, respectively. Extracted plasma and medium samples 
were each dissolved in 1 μl of ethanol and reconstituted in the incubation buffer, 0.2 M 
NaAc solution at pH 5.0. Sulfated vitamin E metabolites were desulfated by sulfatase 
(sulfatase from Helix pomatia S9626, purchased from Sigma) at 30 U/ml (dissolved in 2 
mg/ml NaCl solution). The enzyme concentration and buffer used in the sulfatase 
treatment were based on the recommendations of the manufacturer (Sigma). After 3h 
or overnight incubation at 37 oC with vortexing during the initial 3h of incubation, 
samples were re-extracted twice with working methanol solution (contains 0.2 mg/ml 
ascorbic acid) and analyzed by HPLC-fluorescence. In the case of quantifying γTE-9'S in 
isolated γTE-9'S solution and vitamin E metabolites in biological samples, internal 
standard δTE-13' was spiked in each sample to a final concentration of 0.5 μM to check 
extraction efficiency and stability of vitamin E metabolites during overnight incubation. 
 
2.10 High-Performance Liquid Chromatography-Fluorescent (HPLC-FL) Assay for 
Measuring Vitamin E Metabolites 
Extracted vitamin E metabolites from cell cultured medium, plasma, feces and animal 
diets (method described in 2.4, 2.5, 2.7 and 2.6, respectively) were resuspended in 
working methanol (0.2mg/ml ascorbic acid) followed by mixing and brief centrifugation 
(10,000 rpm for 2 min). The supernatant was transferred to a vial and injected by Hitachi 







HPLC and detected by a Shimadzu RF-10AXL spectrofluorometric detector (Shimadzu, 
Columbia, MD). The excitation and emission wavelengths were set at292 and 327 nm, 
respectively. The samples were injected through a Hitachi L-7200 auto-sampler (San 
Jose, CA). The mobile phases were A (35% acetonitrile and 65% 10 mM ammonium 
acetate at pH 4.3) and B (96% acetonitrile and 4% 10 mM ammonium acetate at pH 4.3). 
The metabolites were separated on a 5 mm Supelcosil LC-18-DB column, 4.6 × 3 × 150 
mm (Supelco, Bellefonte, PA), using a flow rate of 1.0 ml/min with the following 
gradient: 100% A for 8 min, linearly increasing to 100% B from 8 to 30 min, 100% B until 
55 min, and then back to 100% A at 56 min. Vitamin E and their metabolites were 
quantified by external standards due to the good linearity between the concentration of 
vitamin E and vitamin E metabolites and their peak area (19). 
 
2.11 Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) 
Extracted samples are analyzed by liquid chromatography-tandem mass spectrometry 
equipment at the Metabolites Profiling Facility at Bindley Bioscience Center. Vitamin E 
pellets were dissolved in working methanol (0.2 mg/ml ascorbic acid) followed by mixing 
and brief centrifugation (10,000 rpm for 2 min). Internal standard, α-CMBHC or δTE-13' 
were spiked into each sample to the final concentration of 0.5 μM. The supernatant was 
transferred to a vial and 10 μl from each sample was injected by Agilent auto-sampler 
(model G1367D). Biological samples, including cell cultured medium, animal feces and 
plasma samples, were injected through an Agilent G1312B binary pump and separated 







MA), using a flow rate of 0.3 ml/min and the following gradient: 100% A for 1 min, 
linearly increasing to 100% B from 1 to 30 min, 100% B until 40 min, and then back to 
100% A at 43 min. Mobile phase A consisted of acetonitrile/ethanol/water 
(165/135/700 v/v/v) and mobile phase B consisted of acetonitrile/ethanol/water 
(539/441/20 v/v/v)(42).  
 
The LC-MS/MS analysis was done with an Agilent 1200 liquid chromatography system 
coupled to an Agilent 6460 Triple Quadrupole Mass Spectrometer equipped with a jet 
stream electrospray ionization (ESI) source (Santa Clara, CA).Multiple reaction 
monitoring (MRM) mode, product ion scanning mode and total ion scanning mode were 
used to analyze each compound. Negative polarity ESI was used with the following 
source conditions: gas temperature 325°C, gas flow 10 L/minute, nebulizer pressure 30 
psi, sheath gas temperature 250°C, sheath gas flow 7 L/minute, capillary voltage 4000 V, 
nozzle voltage 1500V, and an electron multiplier voltage of-300V. In total ion scanning 
mode, the range of precursor ion mass-to-charge ratio was set between 100 and 1000. 
In product ion scanning mode, the mass-to-charge ratio of the precursor ion was set at 
453, 479, 521 or 427 to analyze γTE-9'S, γTE-11'S, γTE-13'S or δTE-13' (2-double-bond 
form), respectively. The collision energy was set at 15, 25, 35 and 45 V to observe the 
fragmentation pattern. The condition of gradient and ion source used in total ion 
scanning mode and product ion scanning mode were the same from those used in 
multiple reaction monitoring mode. All data was evaluated with Agilent Mass Hunter 







2.12 Optimization of MS/MS Parameters of LC-MS/MS Analysis 
MS/MS parameters, also called the acquisition method, specify the conditions by which 
the Agilent 6460 QQQ mass spectrometer acquired data from the samples. These 
parameters include precursor ion mass, product ion mass, collision energy, polarity, etc. 
These parameters were optimized by conducting product ion scanning which allows 
comparison of the intensity of varied fragmentation conditions. The following table is a 









Table 2.1 Optimized MS/MS Parameters 






α-CEHC (α-3’-COOH) 277.2 233 120 10 
α-CMBHC (α-5’-COOH) 319.2 150 180 20 
α-CMHHC (α-7’-COOH) 347.2 163 180 20 
αT-9' 389.3 163 120 35 
αT-11' 417.3 163 120 35 
αT-13' 459.4 163 120 35 
αT-13’-OH 445.4 163 120 35 
α-Tocopherol 429.4 163 120 20 
     
δ-CEHC (δ-3’-COOH) 249.1 205 120 10 
-SO3-CEHC 329.1 135 120 45 
δ-CMBHC (δ-5’-COOH) 291.2 135 180 20 
δ-CMHHC (δ-7’-COOH) 319.2 135 180 20 
δT-9' 361.3 135 120 35 
δT-11' 389.3 135 120 35 
δT-13'-OH 417.3 135 120 35 
δT-13' 431.3 135 120 35 
δT-9'S 441.2 135 120 45 
δT-11'S 469.2 135 120 45 
δT-13'S 511.3 135 120 45 
δ-Tocopherol 401.4 135 120 35 
     
δTE-5' (1 double bond) 289.2 135 120 35 
δTE-7' (1 double bond) 317.2 135 120 35 
δTE-9' (1 double bond) 359.2 135 120 35 
δTE-9' (2 double bond) 357.2 135 120 35 
δTE-11' (2 double bond) 385.3 135 120 35 
δTE-11' (1 double bond) 387.3 135 120 35 
δTE-13'-OH  411.3 135 120 35 
δTE-13' (3 double bond) 425.3 135 120 30 
δTE-13'-2 (2 double bond) 427.3 135 120 30 
δTE-9'S (1 double bond) 439.2 135 120 45 









Table 2.1 Continued 






δTE-11'S (2 double bond) 465.2 135 120 45 
δTE-11'S (1 double bond) 467.3 135 120 45 
δTE-13'S (3 double bond) 505.2 135 120 45 
δTE-13'S (2 double bond) 507.3 135 120 45 
-tocotrienol 395.3 135 120 35 
     
γ-CEHC (γ-3’-COOH) 263.1 219 120 5 
γ-CMBHC (γ-5’-COOH) 305.2 149 180 20 
γ-CMHHC (γ-7’-COOH) 333.2 149 180 20 
γT-9' 375.3 149 120 40 
γT-11' 403.3 149 120 40 
γT-13'-OH 431.4 149 120 40 
γT-13' 445.3 149 120 40 
γT-SO3-CEHC 343.1 149 120 30 
γT-9'S 455.2 149 120 45 
γT-11'S 483.3 149 120 45 
γT-13'S 525.3 149 120 45 
γ-Tocopherol 415.4 149 120 40 
     
γTE-5’ (1 double bond) 303.2 149 120 25 
γTE-7’ (1 double bond) 331.2 149 120 25 
γTE-9' (2 double bond) 371.2 149 120 25 
γTE-9' (1 double bond) 373.3 149 120 25 
γTE-11' (2 double bond) 399.3 149 120 25 
γTE-11' (1 double bond) 401.3 149 120 25 
γTE-13'-OH (3 double bond) 425.3 149 120 35 
γTE-13' (3 double bond) 439.3 149 120 35 
γTE-13' (2 double bond) 441.3 149 120 35 
γTE-9'S (2 double bond) 451.2 149 120 45 
γTE-9'S (1 double bond) 453.2 149 120 45 
γTE-11'S (2 double bond) 479.2 149 120 45 
γTE-11'S (1 double bond) 481.2 149 120 45 
γTE-13'S (3 double bond) 519.3 149 120 45 
γTE-13'S (2 double bond) 521.3 149 120 45 







2.13 Quantitation of Vitamin E and Metabolites by LC-MS/MS Assay 
A mixture of 100 μM of each of the vitamin E standards, namely γ-CEHC, α-CEHC, δTE-
13', δT-13', δT, γT (for the quantification of animal plasma and fecal samples, also 
included γTE-9'S and αT standards) was step-wise diluted to 10 μM, 1 μM, 0.5 μM, 0.1 
μM and 0.05 μM (for the quantification of animal plasma and fecal samples, diluted the 
standard mixture to 5 μM, 1 μM and 0.2 μM instead). Standard curve and R2 value was 
calculated to examine the linearity of each standard. Usually the response of LC-MS/MS 
is in linear relationship to each standard's concentration. Concentration of vitamin E 
metabolites in samples are calculated by the external standard with the most similar 
structure and its peak area at a similar range as the unknown sample. Usually the peak 
area of the external standard is averaged by its adjacent points on the standard curve 
that fall in the linear range. 
 
2.14 Isolation of γTE Metabolites from A549 Cells Cultured Medium 
Medium of A549 cells cultured with 20 μM of γTE for 72h was collected and extracted 
by working methanol (0.2 mg/ml ascorbic acid) and hexane. Extracted medium sample 
was injected by HPLC auto-sampler and detected by ultraviolet (UV) detector 
(UVD340U) with excitation wavelength at 292 nm. The column and condition of gradient 
was the same as those used in HPLC-fluorescent assay. Eluent was collected when a 
peak appeared on the chromatogram. The components of these isolated γTE metabolite 








2.15 Quantification of Isolated γTE-9'S by HPLC-Fluorescence-UV Analysis 
In order to quantify sulfated vitamin E metabolites, concentration of isolated γTE-9'S 
was measured by an HPLC-fluorescence-UV (HPLC-FL-UV) assay. Concentrated isolated 
γTE-9'S solution was incubated with incubation buffer (0.2 M NaAc solution) or sulfatase 
solution (20 mg/ml dissolved in 2 mg/ml NaCl solution) at 30 U/ml at 37 oC for 3 h at pH 
5.0. Each sample was treated with 0.2 mg/ml ascorbic acid as antioxidant. During the 3 h 
incubation, each sample was gently vortexed each 15 min. After incubation, internal 
standard δTE-13' was spiked in each sample to the final concentration of 0.5 μM prior to 
methanol extraction. Each sample was then dried under N2 and resuspended in working 
methanol (contains 0.2 mg/ml ascorbic acid) and injected by HPLC auto-sampler. Eluents 
were separated by the condition stated in section 2.9 and were detected by the UV 
detector and the fluorescent detector. 
 
2.16 Animal Study 
All animal studies were approved by the Purdue Animal Care and Use Committee. Male 
Wistar rats (230 - 260 g) (Charles River) were caged separately and routinely consumed 
a control diet (2018 Teklad Global 18% Protein Rodent Maintenance diet, Harlan Teklan) 
and tap water. Rats were grouped randomly and gavaged with a single dose of γT at 10, 
50 or 100 mg/kg body weight, γTE at 10 or 50 mg/kg body weight or tocopherol-stripped 
corn oil for rats in the control groups. Rats were euthanized 6 h following the gavage 









Figure 2.3 Design of Animal Study with Rats 
Rats were fed a control diet and gavaged with γT at 10, 50 or 100 mg/kg b.w., γTE at 10 









In another study, Male Balb/c mice (5–6weeks) from Harlan (Indianapolis, IN) were 
single-housed under controlled temperature and were given unrestricted access to diets 
and water. Mice were randomly grouped into control, γT supplementation and δT 
supplementation groups. Mice in the control group received control diet (AIN-93G) 
while the supplementation groups received diet fortified with γT or δT at 0.1% diet. 
After a week of acclimatization and diet supplementation (for the supplementation 
group), mice were given an intraperitoneal injection of azoxymethane (AOM) at 10 
mg/kg to induce colon cancer. A week following the AOM injection, colitis was induced 
in all animals by 7 days of administration of 1.5% DSS (dextran sodium sulfate) in 
drinking water. Animals were observed for another 18 weeks and euthanized on day 
140 following the AOM injection. Plasma was collected from these animals. Their food 












Figure 2.4 Design of Animal Study with Mice 
Male mice were supplemented with control diet (AIN-93G), diet fortified with 0.1% of γT 
or δT. After a week, mice were injected AOM at 10 mg/kg b.w. to induce colon 
carcinogenesis. Another week later, colitis was induced by administration of 1.5% of DSS 
in drinking water. Water was changed to normal tap water after a week of DSS 
administration. Animals were observed for another 18 weeks then euthanized. Plasma 









CHAPTER 3. RESULTS 
3.1 Extraction Efficiency 
In order to obtain the optimum ratio of volume of organic solvent versus biological 
samples, vitamin E standards were spiked in DMEM, FBS and ethanol at the same 
concentration. These vitamin E standards were then extracted from DMEM and FBS 
samples, mimicking the biological samples, with varied volumes of hexane and working 
methanol (0.2 mg/ml ascorbic acid) and injected by HPLC auto-sampler and analyzed by 
fluorescent assay. The recovered concentration of standards are calculated by the peak 
area of directly injected ethanol dissolved vitamin E standards. To validate the optimum 
extraction method, extraction efficiency and inter-day, intra-day variation were 
calculated based on the recovered concentration of vitamin E standards. 
 
The extraction efficiency result shows that for FBS samples, 6 volumes of working 
methanol (0.2 mg/ml ascorbic acid) and 12 volumes of hexane with another extraction 













In four parallel experiments, FBS/working methanol/hexane/working methanol (1/6/12/4 v/v/v/v) extraction method yields 97% 
recovery rate of γ-CEHC, 89% of α-CEHC, 96% of α-CMBHC, 98% of δTE-13', 95% of δT-13', 107% of δT and 101% of γT. The inter-
day and intra-day variation of all standards are within 11%. 
 
 External Standards 
 γ-CEHC α-CEHC α-CMBHC δTE-13' δT-13' δT γT 
Average Extraction 
Efficiency 97% 89% 96% 98% 95% 107% 101% 
Inter-Day Variation 3% 11% 6% 10% 5% 11% 8% 







3.2 Optimization of LC-MS/MS Acquisition Method for Sulfated γTE Metabolites 
3.2.1 Identification of Profile of Isolated γTE Metabolites by LC-MS Total Ion Scan 
In order to optimize the MS/MS parameter of sulfated γTE metabolites, γTE metabolites 
were separated from A549 cells culture medium using HPLC-UV assay. These isolated 
metabolites were first identified by total ion scan LC-MS assay with negative ESI. The 
range of ion mass was set between 100 - 1000. The chromatogram was then extracted 
















As shown in Figure 3.1, the major ion in isolated peak 1 displayed an m/z of 453.2, which 
is consistent with that of γTE-9'S ([M-Z]- = 453.2) while m/z of 479.2, 521.2 and 373.2 
displayed in other isolated peaks suggest that they might be γTE-11's, γTE-13'S and γTE-
9'. Their profile needs to be further confirmed by their fragmentation pattern by 







Table 3.2 Intensity of Ions by Total Ion Scan of LC-MS Analysis 
Peak # m/z Value Peak Profile Retention Time (min) Peak Intensity 
1 453.2 γTE-9'S 20.16 5.5E+07 
2 453.2 γTE-9'S 20.10 2.4E+07 
2 479.2 γTE-11'S 21.47 2.5E+08 
3 453.2 γTE-9'S 20.10 1.2E+07 
3 479.2 γTE-11'S 21.46 2.8E+07 
4 479.2 γTE-11'S 21.48 7.7E+06 
4 521.2 γTE-13'S 24.82 2.1E+07 
5 521.2 γTE-13'S 24.83 2.7E+08 
6 373.2 γTE-9' 24.73 1.6E+08 
 
Sample labeled in bold, isolated γTE metabolite peak 1, 2, 5 and 6 are most abundant in 
γTE-9'S, γTE-11'S, γTE-13'S and γTE-9' respectively, among all the samples. Based on the 
intensity of the ions detected in isolated γTE metabolites, product ion scan MS/MS 








Figure 3.2 Molecular Structure of Ionized Sulfated γTE Long Chain Carboxychromanols 
After negative mode ionization, the sulfated γTE long chain carboxychromanols are 
deprotonated thus loses 1molecular weight. The parental ion mass of γTE-9'S, γTE-11'S 
and γTE-13'S, would be 453.2, 479.2 and 521.2, respectively. The ion mass detected by 






3.2.2 Identification of Profile of Isolated γTE Sulfated Metabolites by Product Ion Scan 
LC-MS/MS Analysis 
Based on the result of total ion scan LC-MS analysis, peak 1 is the major peak of γTE-9'S, 
peak 2 and peak 5 are most abundant in γTE-11'S and γTE-13'S, respectively. Product ion 
scan LC-MS/MS analysis was performed on these isolated metabolites to confirm the 
profile of these metabolites and optimize the MS/MS parameters to acquire the highest 
intensity of these sulfated γTE metabolites. The fragmentation pattern of these 
metabolites in MS/MS mode would suggest the structure of these molecules which 









Figure 3.3 Chromatogram and MS/MS Spectrum of Product Ion Scan LC-MS/MS Analysis 







Figure 3.3.a is the chromatogram of product ion scan analysis of isolated γTE metabolite 
peak 1 with MS/MS mode. 3.3.b, c, d, e are MS/MS spectrum of the product ions 
generated from precursor ion with m/z of 453.2 at collision energy level of 15, 25, 35 
and 45 V, respectively. The major product ion in figure 3.3.b with m/z of 373, suggests 
the presence of SO3 group in the molecular structure. The major product ion in figure 
3.3.c and 3.3.d with m/z of 229 and 149, respectively, suggests retro-Diels-Alder 
fragmentation of the break in the bond between the O-1 and C-2 position and another 
bond between the C-3 and C-4 position in the chromanol structure, which is commonly 
observed with vitamin E metabolites (Figure 3.3). Based on these fragmentation 
patterns, we are able to confirm the isolated metabolite in peak 1 is γTE-9'S. The 
product ion with m/z of 149 at collision energy of 45 V showed the highest intensity 








Figure 3.4 Retro-Diels-Alder Fragmentation of γTE-9'S 
Retro-Diels-Alder fragmentation pattern has been observed in many chromanol 
structure molecules. It is also a common fragmentation pattern of vitamin E metabolites 
(43). In MS/MS mode, at 30 V of collision energy level, the bond between O-1 and C-2 









Figure 3.5 Chromatogram and MS/MS Spectrum of Product Ion Scan LC-MS/MS Analysis 







Figure 3.5.a is the chromatogram of product ion scan analysis of isolated γTE metabolite 
peak 2 with MS/MS mode. 3.5.b, c, d, e are MS/MS spectrum of the product ions 
generated from precursor ion with m/z of 479.2 at collision energy level of 15, 25, 35 
and 45 V, respectively. The major product ion in figure 3.5.b with m/z of 399, suggests 
the presence of SO3 group in the molecular structure. The major product ion in figure 
3.5.c and 3.5.d with m/z of 229 and 149, respectively, suggests retro-Diels-Alder 
fragmentation of the break in the bond between the O-1 and C-2 position and another 
bond between the C-3 and C-4 position in the chromanol structure (Figure 3.4). Based 
on these fragmentation patterns, we are able to confirm the isolated metabolite in peak 
2 is γTE-11'S. The product ion with m/z of 149 at collision energy of 45 V showed the 










Figure 3.6 Chromatogram and MS/MS Spectrum of Product Ion Scan LC-MS/MS Analysis 







Figure 3.6.a is the chromatogram of product ion scan analysis of isolated γTE metabolite 
peak 5 with MS/MS mode. 3.6.b, c, d, e are MS/MS spectrum of the product ions 
generated from precursor ion with m/z of 521.2 at collision energy level of 15, 25, 35 
and 45 V, respectively. The major product ion in figure 3.6.b with m/z of 441, suggests 
the presence of SO3 group in the molecular structure. The major product ion in figure 
3.6.c and 3.6.d with m/z of 229 and 149, respectively, suggests retro-Diels-Alder 
fragmentation of the break in the bond between the O-1 and C-2 position and another 
bond between the C-3 and C-4 position in the chromanol structure (Figure 3.4). Based 
on these fragmentation patterns, we are able to confirm the isolated metabolite in peak 
5 is γTE-13'S. The product ion with m/z of 441 at collision energy of 25 V showed the 










Figure 3.7 Chromatogram and MS/MS Spectrum of Product Ion Scan LC-MS/MS Analysis 







Figure 3.7.a is the chromatogram of product ion scan analysis of isolated γTE metabolite 
peak 6 with MS/MS mode. 3.7.b, c, d, e are MS/MS spectrum of the product ions 
generated from precursor ion with m/z of 373.2 at collision energy level of 15, 25, 35 
and 45 V, respectively. The common major product ion in figure 3.7.c, 3.7.d and 3.7.e 
with m/z of 149, suggests retro-Diels-Alder fragmentation of the break in the bond 
between the O-1 and C-2 position and another bond between the C-3 and C-4 position 
in the chromanol structure (Figure 3.4). Based on its fragmentation pattern, we are able 
to confirm the isolated metabolite in peak 6 is γTE-9'. The product ion with m/z of 149 at 
collision energy of 25 V, showed the highest intensity among all the product ions 
generated at different collision energy levels, although only slightly higher than the 







3.2.3 Confirmation of Optimum MS/MS Parameters of Isolated γTE Metabolites by LC-
MS/MS Analysis in Multiple-Reaction Monitoring (MRM) Mode 
In order to confirm that the intensity of product ion generated in LC-MS/MS product ion 
scan mode would be consistent with that generated in MRM mode, isolated γTE 
metabolites were analyzed by multiple reaction monitoring (MRM) mode LC-MS/MS 
assay. The most abundant product ion generated at each collision energy level was 
added to the list of MS/MS parameter (Table 3.3) prior to analysis to confirm the most 

















Energy (V) Polarity 
γTE-9’S 453.1 373.0 25 Negative 
γTE-9’S 453.1 229.1 35 Negative 
γTE-9’S 453.1 149.1 45 Negative 
γTE-11’S 479.1 399.0 25 Negative 
γTE-11’S 479.1 229.1 35 Negative 
γTE-11’S 479.1 149.1 45 Negative 
γTE-13’S 521.1 441.0 25 Negative 
γTE-13’S 521.1 229.1 35 Negative 









Figure 3.8 Chromatograms of LC-MS/MS Analysis of Isolated γTE-9'S with Different 







As shown in Figure 3.8, the sensitivity of MRM mode LC-MS/MS analysis with the 
transition 453 → 149 at collision energy of 45 V is the highest among all the examined 
acquisition parameters of γTE-9'S, followed by the transition 453 → 373 at 25 V and 453 
→ 229 at 35 V. This result is consistent with the result of product ion scan analysis of 
γTE-9'S. Thus the optimum MS/MS parameters ofγTE-9'S for MRM mode LC-MS/MS 
analysis are: precursor ion with m/z of 453.2, product ion with m/z of 149.1, collision 








Figure 3.9 Chromatograms of LC-MS/MS Analysis of Isolated γTE-11'S with Different 







As shown in Figure 3.9, the sensitivity of MRM mode LC-MS/MS analysis with the 
transition 479 → 149 at collision energy of 45 V is the highest among all the examined 
acquisition parameters of γTE-11'S. The intensity of peaks detected by other parameters, 
namely 479 → 399 at 25 V and 479 → 229 at 35 V, are a lot lower compared to 479 → 
149 at 45 V. This is consistent with the result of product ion scan analysis of γTE-11'S. 
Thus the optimum MS/MS parameters of γTE-11'S for MRM mode LC-MS/MS analysis 









Figure 3.10 Chromatograms of LC-MS/MS Analysis of Isolated γTE-13'S with Different 







As shown in Figure 3.10, the sensitivity of MRM mode LC-MS/MS analysis with the 
transition 521 → 149 at collision energy of 45 V is the highest among all the examined 
acquisition parameters of γTE-13'S. The intensity of peak detected by the transition 521 
→ 441 at 25 V is only 10 % smaller while the intensity of peak detected by the transition 
521 → 229 at 35 V is only 1/3 compared to the other two transitions. However, in 
product ion scan LC-MS analysis of γTE-13'S, the intensity of the product ion with m/z of 
441 at 25 V was 25% higher than that of m/z of 149 at 45 V. The difference in sensitivity 
between product ion scan mode and MRM mode might explain the situation. For LC-
MS/MS analysis of γTE-13'S in MRM mode, the optimum parameters are: precursor ion 








3.3 Quantification of Isolated γTE-9'S Standard Solution by HPLC-FL-UV 
In order to quantify γTE-9'Sas an external standard, γTE-9'Swas isolated from cell 
cultured medium and was quantified by HPLC-UV detection coupled with fluorescent 
assay. Due to lack of external standards for the sulfated metabolite we were not clear 
about their linearity and sensitivity in UV and FL detection, quantification of γTE-9'S 
requires enzyme deconjugation to γTE-9' which can be quantified by δTE-13' by HPLC-
UV detection. It has been demonstrated by our previous study (not published data) that 
UV intensity is not as sensitive as the fluorescence intensity to the chromanol ring 
configuration and side-chain modification. This makes δTE-13'an excellent external 
standard for γTE-9'. However, the intensity of the UV signal appears to be around 100 
times lower than the intensity of the fluorescence signal. In order for the UV detector to 
detect γTE-9', we used concentrated γTE-9'S solution and converted around 90% into 
γTE-9' by the sulfatase. The concentration of γTE-9'S was calculated by adjusting the 
concentration of γTE-9' quantified by HPLC-UV analysis by the percentage converted 
γTE-9'S as measured by HPLC-fluorescent assay. Due to the linear relationship between 
fluorescent intensity and percentage of solvent B, fluorescent intensity is lower for γTE-
9'S compared to γTE-9' (it elutes later than γTE-9'S). Thus connecting the fluorescent 
detector with the UV detector allows simultaneous detection of γTE-9'S (by the 
fluorescent detector) and γTE-9' (by the UV detector). The recovery rate of internal 
standard (δTE-13') spiked in each sample was within 85% - 95%. A sample calculation of 
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The experiment was repeated on 4 different days. The average concentration of γTE-9'S 
in the concentrated isolated sample is 1.48 ± 0.044 mM. 
 
The concentrated γTE-9'S standard solution was diluted 10 times to 148 μM with 
ethanol and stored at -20 oC. It was further diluted to 10 μM along with other vitamin E 
standards (γ-CEHC, α-CEHC, δTE-13', δT-13', δT, γT and αT) by step-wise dilution in order 







3.4 Analysis of Tocopherol and δTE-13' in Animal Diet Pellets by HPLC-FL 
Two forms of animal diets, control (Ctrl) diet (AIN-93G) and 250 mg/kg δTE-13' 
supplemented diet (purchased from Dyets Inc., Bethlehem, PA), were extracted and 
analyzed by HPLC-FL. The concentrations of components in different diets were 
calculated by external standards. The primary purpose for this experiment was to 
examine the concentration of δTE-13' in the diet to more accurately calculate the δTE-
13'treatment given to the animals. Four independent extractions and analyses were 







Table 3.5 Concentration of Vitamin E in the Control Diet and δTE-13' Fortified Diet 
 AIN-93G Diet AIN-93G+δTE-13’ Diet 
 
Average Conc. (mg/kg) Average Conc. (mg/kg) 
γ-CEHC 27.72± 13.58a 28.38± 13.33a 
δTE-13' n.d. 218.86± 36.30 
δT 7.47± 2.56a 7.93± 1.08a 
γT 25.12± 6.56a 22.41± 7.55a 
n=3 
Between the control diet and treatment diet, there's no significant difference in 
concentration of γ-CEHC, δT and γT. There's significantly (p = 0.005) higher 
concentration of δTE-13'in the treatment diet (218.86 ± 36.30 mg/kg). δTE-13' wasn't 
detected in the control diet. The average concentration is 10% smaller than the 
concentration suggested by the manufacturer but considering the loss during extraction 
and variation of fluorescent detection the difference is acceptable. The methanol 
extraction probably compromised the recovery rate of tocopherols due to the poor 







3.5 Analysis of Vitamin E and Metabolites in Feces of δTE-13' Supplemented Mice by 
HPLC-FL Analysis 
Feces of mice fed with control diet or δTE-13' supplemented diet were extracted with 
methanol and analyzed by HPLC-FL assay. In 5 independent experiments, feces of rats 
fed with control diet or δTE-13' supplemented diet were extracted and analyzed. 







Table 3.6 Concentration of Vitamin E and Metabolites in Mice Feces 
 Ctrl Diet Feces δTE-13' Diet Feces 
Peak Profile Average Conc. (nmol/g) Average Conc. (nmol/g) 
δTE-13' n.d. 1475.18± 565.16 
δT 14.97± 8.49a 14.84± 2.06a 
γT 92.56± 25.77a 91.03± 18.91a 
αT 296.05± 70.85a 310.56± 69.69a 
n=3 for feces of mice fed with control diet;  
n=4 for feces of mice fed with δTE-13' supplemented diet 
 
There's no significant difference in the concentration of tocopherols between feces of 
mice fed with ctrl diet and δTE-13' supplemented diet. However, there's significantly (p 
= 0.002) higher concentration of δTE-13' in feces of mice fed with δTE-13' supplemented 
diet (1475.18 ± 565.16 nmol/g) compared to feces of mice fed with the control diet (not 
detected).  
 
Several peaks which eluted earlier than δTE-13' were detected by the fluorescent 
detector. However, due to lack of external standard, we couldn't identify the profile of 
these metabolites. These samples were then analyzed by LC-MS/MS with MRM mode to 







3.6 Analysis of Vitamin E and Metabolites in Feces of δTE-13' Supplemented Mice by 
LC-MS/MS Analysis 
The remaining fecal samples after the HPLC-FL analysis were stored at -20 oC and 
analyzed by LC-MS/MS with MRM mode. MRM mode LC-MS/MS analysis allows 
identification of each individual metabolite due to their unique transitions (precursor 
ion and product ion m/z value) while in HPLC-FL analysis the profile of the metabolites 
were suggested by the retention time. In the case of lack of external standards or peaks 
overlapping with each other, the profile of the peaks could not be identified from 
fluorescent chromatogram. As shown in the result of HPLC-FL analysis of animal diets, 
animals were given multiple forms of vitamin E. Our previous studies (data not 
published) with HPLC-FL analyzed A549 cells culture medium incubated with vitamin E 
suggested that metabolites of different forms of vitamin E would overlap on the 
fluorescent chromatogram. Thus, for samples that contained multiple forms of vitamin E 
metabolites, LC-MS/MS MRM mode analysis is necessary to identify profile of the 
metabolites. LC-MS/MS analysis in MRM mode also eliminates background noise since 
the triple-quadruple instrument only acquires ions with m/z ratio specified by the 
MS/MS parameters.  
 
Mixed vitamin E standards at different concentrations were also injected to calculate 
concentration of metabolites and tocopherols in feces samples. The inter-day variation 







3.6.1 Analysis of Vitamin E and Metabolites in Feces of δTE-13' Supplemented Mice by 
LC-MS/MS Analysis with Original MRM Acquisition Method 
The δTE-13' fortified in the animal diet had 3 double bonds in its side chain (Figure 3.11). 
However, previous studies using A549 cell cultured medium suggested the structure of 
γTE 13-carbon side-chain metabolite have 2 double bonds in its side-chain (31). Since 
our primary goal was to quantify the bioavailability of δTE-13' in biological environment 
and we were not clear of the metabolism of δTE-13' (3-double-bond) in mice at that 
point, the MS/MS parameter of 2-double-bond form of δTE-13' (Figure 3.11) was not 
included in the acquisition method. The MS/MS parameter of 3-double-bond form of 
δTE-13' (precursor ion [M-H]- = 425, product ion [M-H]- = 135, collision energy = 35 V) 
was postulated from the MS/MS parameter of γTE-13', which has similar molecular 







Table 3.7 Concentration of Vitamin E Metabolites in Feces of Mice Fed with Control Diet 
or δTE-13' Supplemented Diet Analyzed by LC-MS/MS Analysis in MRM Mode with 
Original MRM Acquisition Method 
Peak Profile 
Ctrl Diet δTE-13’ Diet  
Average Conc. (nmol/g) Average Conc. (nmol/g) 
δTE-9' n.d. 14.51 ± 4.78 
δTE-11' n.d. 82.39 ± 27.03 
δTE-13' n.d. 147.30 ± 151.93 
δT-13' 5.58 ± 2.76a 4.55 ± 1.47a 
γT-9' 3.08 ± 1.68a 2.37 ± 0.84a 
γT-11' 5.20 ± 2.34a 3.27 ± 1.07a 
γT-13' 17.87 ± 10.47a 11.60 ± 3.89a 
δT-13'-OH 5.81 ± 3.23a 4.16 ± 1.35a 
γT-13'-OH 11.82 ± 7.01a 8.05 ± 2.51a 
n=5 
 
The concentration of δTE-13' (3-double-bond form) calculated from LC-MS/MS analysis 
(147.3 ± 151.93 nmol/g) is 10X smaller than the concentration calculated from HPLC-FL 
analysis (1475.18 ± 565.16 nmol/g).  
 
We speculate that this difference might due to under-estimation of δTE-13' by LC-
MS/MS analysis with MRM mode. δTE-13' (3-double-bond form) might have been 
metabolized to 2-double-bond form in mice. In order to find out the form of δTE-13' 
metabolite in mice fecal samples, total ion scan LC-MS analysis will be performed on 







Figure 3.11 Molecular Structure of Ionized 2-Double-Bond and 3-Double-Bond Form of 
δTE-13' 
Animal diet fortified with δTE-13' with 3 double bonds was given to the animals. This 
molecule is possibly metabolized to the 2-double-bond form in mice since previous 
study showed in A549 cells culture medium incubated with γTE at 20 μM for 72 h, the 
13'-carboxychromanol of γTE were identified by LC-MS/MS to be 2-double-bond form. 
However, the existence of 2-double-bond form of δTE-13' needs to be confirmed by 






3.6.2 Identification and Optimization of MS/MS Parameters of δTE-13' Metabolites in 
Mice Feces by LC-MS Analysis Total Ion Scan and Product Ion Scan Mode 
In order to find out the form of δTE-13' metabolite in mice feces, samples were analyzed 
by total ion scan LC-MS analysis in the range of 200 - 500 m/z value in which the ion 
mass of δTE-13' falls into. The chromatogram was further analyzed in the range of 10 
m/z value to examine δTE-13' metabolites detected by the instrument.  
 
The fecal samples were further analyzed by product ion scan LC-MS/MS analysis 
targeting a precursor ion with m/z of 427.1 (2-double-bond form of δTE-13') and 385.2 
(δTE-11') with collision energy at 5/15/30/45 V to examine its fragmentation pattern 







Figure 3.12 Extracted Ion Chromatogram of δTE-13' Supplemented Mice Feces Sample and Blank (methanol) in 420 - 430 m/z 
 
As shown in the chromatogram, there are 3 peaks on the extracted ion chromatogram of δTE-13' supplemented mice feces 
sample, 1 of them in common with the extracted ion chromatogram of blank sample. Peak 1 and peak 3 might be our 
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Figure 3.13 MS Spectrum of Peak 1 and 3 in Extracted Ion Chromatogram of δTE-13' Supplemented Mice Fecal Samples in 420 - 
430 m/z 
In peak 1 spectrum there was no ion detected within 420 to 430 m/z value. But in peak 3 spectrum, ion with m/z of 427.1 was 
detected. Based on its ion mass, this compound is speculated to be δTE-13' with 2-double-bond. However it needs to be 





(2 double bonds) 







Figure 3.14 Chromatogram of Product Ion Scan LC-MS/MS Analysis of δTE-13' 
Supplemented Mice Feces at m/z of 427 
As shown on figure 3.14, there are 2 separate peaks on the chromatogram of product 
ion scan LC-MS/MS analysis of δTE-13' supplemented mice feces targeting a precursor 
ion m/z of 427. The MS/MS spectrum of these 2 peaks at different collision energy levels 








Figure 3.15 MS/MS Spectrum of Peak 1 of Product Ion Scan of δTE-13' Supplemented 
Mice Feces at m/z of 427 with Various Collision Energy Levels 
Figures 3.15.a, b, c, d represent the MS/MS spectrum of peak 1 in the chromatogram of 
product ion scan of δTE-13' supplemented mice feces at m/z of 427 at collision energy 
level of 5, 15, 30 and 45 V, respectively. The fragmentation of the compound at collision 
energy at 5 or 15 V was poor. At 30 V and 45 V of collision energy, the major product ion 
with m/z of 163 was generated at similar levels but slightly higher at 30 V of collision 
energy. We did not recognize the fragmentation pattern of this particular ion from its 
precursor ion, δTE-13'. We've only observed the product ion with m/z of 163 from α-






ring structure. We could not identify the profile of peak 1 on the product ion scan 









Figure 3.16 MS/MS Spectrum of Peak 2 of Product Ion Scan of δTE-13' Supplemented 
Mice Feces at m/z of 427 with Various Collision Energy Levels 
Figures 3.16.a, b, c, d represent the MS/MS spectrum of peak 2 in the chromatogram of 
product ion scan of δTE-13' supplemented mice feces at m/z of 427 at collision energy 
level of 5, 15, 30 and 45 V, respectively. The fragmentation of the compound at collision 
energy at 5 or 15 V was poor. At 30 V and 45 V of collision energy, the m/z value of the 
major product ion generated was both 135. The level of the major product ion 
generated at 30 V of collision energy was higher than that at 45 V. This fragmentation 
pattern is similar to those observed in other vitamin E metabolites. Based on the 






bond form of δTE-13' and its optimum MS/MS parameters: precursor ion at m/z of 
427.2, product ion at m/z of 134.9, collision energy at 30 V. This MS/MS parameter was 
implemented in the acquisition method of QQQ instrument and feces samples were re-








Figure 3.17 Chromatogram of Product Ion Scan LC-MS/MS Analysis of δTE-13' 
Supplemented Mice Feces at m/z of 385.2 
On the chromatogram of product ion scan LC-MS/MS analysis of δTE-13' supplemented 
mice feces at m/z of 385.2, there are 2 major peaks. The bigger peak (Peak 2) eluting at 
29.8 min does not match the retention time of our compound of interest (δTE-11' RT = 
24.5 min). Peak 1 eluting at 24.5 min matches the retention time of our interest 
compound, δTE-11'. The MS/MS spectrum of this peak at various collision energy levels 








Figure 3.18 MS/MS Spectrum of Peak 1 of Product Ion Scan of δTE-13' Supplemented 
Mice Feces at m/z of 385.2 with Various Collision Energy Levels 
Figures 3.18.a, b, c, d represent the MS/MS spectrum of peak 1 in the chromatogram of 
product ion scan of δTE-13' supplemented mice feces at m/z of 385.2 at collision energy 
level of 5, 15, 30 and 45 V, respectively. The fragmentation of the compound at collision 
energy at 5 or 15 V was poor. At 30 V and 45 V of collision energy, the m/z value of the 
major product ion generated was both 135. The level of the major product ion 
generated at 30 V of collision energy was higher than that at 45 V. This fragmentation 






peak as δTE-11' and its optimum MS/MS parameters are: precursor ion m/z = 385.2, 
product ion m/z = 134.9, collision energy = 30 V. The optimum MS/MS parameter is 
consistent with the current parameters in the acquisition method. 
 
3.6.3 Analysis of Vitamin E and Metabolites in Feces of δTE-13' Supplemented Mice by 
LC-MS/MS Analysis with Modified MRM Acquisition Method 
After identifying the 2-double-bond form of δTE-13' and its optimum MS/MS 
parameters, feces samples were re-analyzed by LC-MS/MS MRM mode analysis to 







Table 3.8 Concentration of Vitamin E Metabolites in Feces from Mice Fed with Control 
or δTE-13’ Supplemented Diet Analyzed by LC-MS/MS Analysis in MRM Mode with 
Modified MRM Acquisition Method 
Peak Profile 
Ctrl Diet δTE-13’ Diet 
Average Conc. (nmol/g) Average Conc. (nmol/g) 
δTE-9' n.d. 10.61 ± 5.36 
δTE-11' n.d. 70.48 ± 24.05 
δTE-13' n.d. 150.82 ± 162.27 
δTE-13' (2 Double Bond) n.d. 294.19 ± 85.41 
δT-13' 5.58 ± 2.76a 4.70 ± 1.76a 
γT-9' 3.08 ± 1.68 n.d. 
γT-11' 5.20 ± 2.34 n.d. 
γT-13' 17.87 ± 10.47a 10.68 ± 4.42a 
δT-13'-OH 5.81 ± 3.23a 4.43 ± 2.08a 
γT-13'-OH 11.82 ± 7.01a 8.29 ± 3.26a 
n=5 
As shown in the table above, the major metabolite in δTE-13' supplemented mice feces 
samples is δTE-13' with 2 double bonds (294.19 ± 85.41 nmol/g). The concentration of 3-
double-bond form of δTE-13' is 150.82 ± 162.27 nmol/g. δTE-11' and 9' were detected at 
lower concentration. The major metabolite excreted in feces of mice after δTE-13' 
supplementation is long chain δTE carboxychromanols. None of these δTE long chain 
metabolites were detected in feces of mice fed with ctrl diet. The 13'-carboxychromanol 
and hydroxylated metabolites from δT and γT were detected in both control and 
supplemented fecal samples. Low levels of 9'- and 11'-carboxychromanol of γT were 






Table 3.9 Comparison of Concentration of δTE-13' in δTE-13' Supplemented Mice Feces 
Samples Calculated from LC-MS/MS MRM Analysis and HPLC-FL Analysis 
Conc. (nmol/g) 
LC-MS/MS Analysis HPLC-FL 
δTE-13' 
(425.1 → 135) 
δTE-13'-2 
(427.1 → 135) Sum of δTE-13' δTE-13' 
Average 150.82 294.19 445.01 1475.18 
StdDev 162.27 85.41 199.38 565.16 
 
Although the newly implemented MS/MS parameter for 2-double-bond form of δTE-13' 
allowed detection of both forms of δTE-13' in the fecal samples, there's still a 3-fold 
difference between the concentration calculated from HPLC-FL analysis and LC-MS/MS 
analysis. We speculate that HPLC-FL analysis over-estimated the concentration of δTE-
13' due to overlapping of the 2 peaks. Since the 2 compounds are very similar in 
structure and polarity, the retention time of δTE-13' with 2 double bonds or 3 double 
bonds are almost the same. Peaks overlapping with each other would influence the 
shape of the peak thus compromise the accuracy of the intensity of the peak. We 







3.7 Optimization of Condition of Complete Deconjugation of Vitamin E Metabolites 
In order to quantify metabolites in conjugates in biological samples, complete 
deconjugation is required to quantify conjugated metabolites more accurately by 
calculating the increase of unconjugated metabolites. MS/MS parameters for sulfated 
conjugates have been set up and optimized with an external standard, γTE-9'S. However, 
we rely on the increase of unconjugated metabolites to calculate other forms of 
conjugated metabolites, such as glucuronide conjugates. Per information from Sigma 
Aldrich, the sulfatase from Helix pomatia exhibits sulfatase activity at 14.2 U/mg (1 U of 
sulfatase deconjugates 1 μmole of sulfated p-nitrocatechol at 37 oC at pH 5.0) and 
glucuronidase activity at 541.8 U/mg (1 U of glucuronidase deconjugates 1 μg of 
phenolphthalein glucuronide at 37oC at pH 5.0). We propose that by optimizing the 
treatment condition, we would be able to achieve complete deconjugation of 
conjugated metabolites in biological samples. 
 
Our study demonstrated that overnight sulfatase treatment completely 
deconjugatedγTE-11'S existing in plasma of rats supplemented with γTE at 50 mg/kg 
after 16 h of sulfatase treatment at 37 oC at pH 5.0. Our study also demonstrated that 
3h incubation desulfated 90% of isolated γTE-9'S. Experiments were conducted using 
A549 cells culture medium incubated with γTE at 20 μM for 72h which contains large 
amounts of long chain sulfated metabolites. Different sulfatase treatment conditions 






Figure 3.19 Desulfation Efficacy of Long Chain Sulfated γTE Metabolites Extracted from Cell Cultured Medium Analyzed 






As seen in the figure, although 30 U/ml sulfatase treatment at 3 h desulfated 90% of 
purified γTE-9'S, in samples with multiple forms of conjugated vitamin E metabolites the 
same condition only achieved desulfation of 47% of γTE-9'S and 11'S. Even if the amount 
of sulfatase was doubled, the desulfation efficacy was still around 40% for γTE-9'S and 
even lower for longer chain sulfates. When incubation was prolonged, 24 h sulfatase 
treatment at 30 U/ml desulfated 94% of γTE-9'S, 86% of γTE-11'S and 66% of γTE-13'S. 
16 h sulfatase treatment at 30 U/ml desulfated a little bit less than 24 h treatment, but 
still achieved 91% and 83% desulfation of γTE-9'S and 11'S, respectively. The initial 
vortexing every 15 min during the first 3 h of incubation seemed to be necessary for the 
complete desulfation as samples without initial vortexing resulted in only 40 - 50% 
desulfation after overnight incubation. Based on these results, the optimum sulfatase 
treatment condition for complete deconjugation is sulfatase treatment at 30 U/ml for 








3.8 Analysis of Vitamin E Metabolites in Animal Plasma and Feces Samples 
Plasma and fecal samples collected from rats or mice gavaged or supplemented with 
vitamin E were extracted with methanol and hexane and analyzed by HPLC-FL or LC-
MS/MS. Plasma samples from rats gavaged with a single dose of γT or γTE was added 
with 0.5 μM of δTE-13' before extraction to ensure extraction efficiency and correct for 
possible loss during the experiment. Plasma samples were treated with or without the 
sulfatase to calculate glucuronide conjugates in the plasma samples. The hexane 
fraction and methanol fraction extracted from each sample were combined and treated 
with an internal standard (0.5 μM of α-CMBHC) before analysis to monitor consistency 
of injection and ionization of the LC-ESI-MS instrument. MS/MS parameters allowed 
identification of each metabolite and tocopherol or tocotrienol, simultaneously. Vitamin 
E metabolites were quantified by external standards with different side chain at 0.2 μM. 
Tocopherols and tocotrienols were quantified by their external standards at 10 μM. The 
internal standard spiked in each sample before analysis (α-CMBHC to a final 






Table 3.10 Concentration of Vitamin E Metabolites in Plasma of Rats Collected 6 h after Single Dose Gavage with γT at 10 or 50 
100 mg/kg Body Weight or Tocopherol-Stripped Corn Oil 
 
Ctrl γT 10 mg/kg γT 50 mg/kg  γT 100 mg/kg 
Peak Profile Average Conc. (μM) Average Conc. (μM) Average Conc. (μM) Average Conc. (μM) 
γ-SO3-CEHC 0.033 ± 0.018 0.13 ± 0.07 0.73 ± 0.35 0.94  ± 0.50 
γ-CEHC 0.12 ± 0.038 0.14 ± 0.069 0.29 ± 0.10 0.24 ±0.04 
"Glucuronidated" γ-CEHC n.d. n.d. n.d. 2.03 ± 0.65 
α-CEHC 0.16 ± 0.080 0.17 ± 0.12 0.25 ± 0.070 0.16 ± 0.047 
γTE-9'S (1DB) 0.017 ± 0.013 0.011 ± 0.010 n.d. 0.010 ±0.0022 
γTE-11'S (2DB) 0.036 ± 0.015 0.051 ± 0.024 0.050 ± 0.026 0.050 ± 0.0086 
γTE-11'S (1DB) n.d. n.d. 0.038 ± 0.026 n.d. 
γT-9'S n.d. 0.11 ± 0.050 0.44 ± 0.28 0.55 ± 0.10 
γT-11'S 0.032 ± 0.038 0.25 ± 0.12 0.96 ± 0.56 0.62 ± 0.26 
γT-13'S n.d. 0.011 ± 0.0022 0.042 ± 0.014 0.070 ± 0.034 
αT-13' n.d. 0.0052 ± 0.00088 0.0043 ± 0.00042 0.0054 ± 0.0019 
γT-9' n.d. n.d. n.d. 0.00035 ± 0.00031 
γT-11' n.d. n.d. n.d. 0.0015 ± 0.00050 
γT-13' n.d. n.d. 0.013 ± 0.0059 0.020 ± 0.0082 
γT-13'-OH n.d. 0.017 ± 0.0029 0.081 ± 0.022 0.0630 ± 0.041 
αT-13'-OH 0.0043 ± 0.0032 0.0063 ± 0.00077 0.0081 ± 0.00029 0.0050 ± 0.0017 
δT 5.48 ± 3.04 3.47 ± 1.91 4.51 ± 1.39 2.48 ± 2.17 
γT n.d. 1.83 ± 1.08 7.45 ± 1.96 9.24 ± 4.96 






Three or five samples in each treatment group were extracted and analyzed. Result of 
LC-MS/MS analysis in MRM mode showed that the major metabolite of γT in rats are 
conjugated γ-CEHC and long chain sulfated carboxychromanols. Among the sulfated 
long chain carboxychromanols detected in plasma of rats gavaged with γT, 11'S has the 
highest concentration among 3 different dosages. As the gavaged dosage increases, the 
amount of γ-CEHC conjugates increased. Tocopherols are also found in rats plasma in all 
groups in relatively high concentration, especially αT, which is poorly metabolized 
compared to δT and γT. Concentration of γT in plasma of rats increased as the gavaged 








Table 3.11 Concentration of Vitamin E Metabolites in Plasma of Rats Gavaged with γTE 
at 10 or 50 mg/kg Body Weight or Tocopherol-Stripped Corn Oil in Ctrls 
 








γ-SO3-CEHC n.d. 0.46± 0.24a 1.60 ± 0.61b 
"Glucuronidated"  
γ-CEHC 0.10 1.15± 0.47 N/A 
γ-CEHC 0.08 0.22± 0.14a 0.25 ± 0.068a 
α-CEHC n.d. 0.13±0.064a 0.17 ± 0.061a 
γTE-9'S (1DB) n.d. 0.27± 0.084a 0.41 ± 0.23a 
γTE-11'S (2DB) 0.017 0.95± 0.34a 1.08 ± 0.79a 
γTE-11'S (1DB) n.d. 0.062± 0.019a 1.02 ± 1.59a 
γTE-13'S (3DB) n.d. 0.041± 0.016a 0.10 ±0.0156b 
γT-9'S n.d. 0.018± 0.0040a 0.026 ± 0.0094a 
γT-11'S n.d. 0.017± 0.0070 n.d. 
γTE-7' (1DB) n.d. n.d. 0.0032 ± 0.00080 
γTE-9' (1DB) n.d. n.d. 0.0051 ± 0.00082 
γTE-11' (2DB) n.d. n.d. 0.0088 ± 0.0015 
γTE-13' (2DB) n.d. 0.0026± 0.0023 n.d. 
γTE-13' (3DB) n.d. 0.0068± 0.0026a 0.022 ±0.0031b 
αT-13' 0.0049 0.0058± 0.0002a 0.0049 ± 0.00035b 
γTE-13'-OH n.d. 0.027± 0.0047a 0.086 ± 0.0060b 
γT-13'-OH n.d. 0.0027± 0.00010a 0.0017 ± 0.00020b 
αT-13'-OH 0.0057 0.0051± 0.0016a 0.0063 ± 0.0017a 
γTE n.d. n.d. 1.16 ± 0.08 
δT 3.59 3.14± 1.26a 4.23 ± 1.84a 
αT 22.80 26.78± 3.12a 21.65 ± 1.31b 







Two plasma samples from the control group and three plasma samples from each 
treatment group was extracted and analyzed by LC-MS/MS with MRM mode. In plasma 
of rats gavaged with a single dose of γTE at 10 or 50 mg/kg body weight, the major 
metabolites are also conjugated γ-CEHC and sulfated long chain carboxychromanols. 
The amount of conjugated γ-CEHC increased 4-fold when the administration dose 
increased 5-fold however the amount of γ-CEHC stayed at a similar level. Interestingly, 
γTE-11'S, the major sulfated long chain metabolite in rats plasma, are found existing 
with both 1 double bond and, more predominantly, 2-double-bonds. There's 
approximately 2-fold increase in the amount of γTE-13'S and 11'S (1-double-bond form) 
when the dosage was increased 5 times, however the amount of 2-double-bond form of 
11'S was similar. In all treatment groups, δT and αT were excreted at relatively high 
concentration and are not influenced by the dose of γTE. In plasma of rats gavaged with 













As shown in Table 3.11 and Figure 3.20, in the plasma of rats collected 6 h following the 
gavage of γTE at 10 or 50 mg/kg b.w., γTE-9'S was only detected in 1-double-bond form, 
the major metabolite γTE-11'S, was detected in both 2-double bond and 1-double-bond 
form but the 2-double-bond metabolite was the predominant form, γTE-13'S was only 
detected in 3-double-bond form. However, as for the unconjugated long chain 
carboxychromanols, γTE-9' was detected only in 1-double-bond form, γTE-11' was only 
detected in 2-double-bond form, γTE-13' was detected in both 2- and 3-double-bond 
forms. These unconjugated long chain carboxychromanols were detected at relatively 






Table 3.12 Concentration of Vitamin E Metabolites in Plasma of AOM-DSS Colon Carcinogenesis Induced Mice Supplemented 
with γT or δT at 0.1% Diet or Control Diet 
Ctrl Diet γT Diet δT Diet 
Peak Profile Average Conc. (μM) Peak Profile Average Conc. (μM) Peak Profile Average Conc. (μM) 
α-CEHC 0.034 ± 0.011 γ-CEHC 0.085 ± 0.031 γ-CEHC 0.012 ± 0.0043 
  
α-CEHC 0.026 ± 0.0067 α-CEHC 0.029 ± 0.0064 
  
γT-9'S 0.040 ± 0.011 δT-9'S 0.032 ± 0.0056 
  γT-11'S 0.032 ± 0.016 δT-11'S 0.045 ± 0.0092 
  γT-13'S 0.0085 ± 0.0042 δT-13'S 0.032 ± 0.0073 
  γT-11' 0.0014 ± 0.0013 δT-13' 0.010 ± 0.0052 
  γT-13' 0.021 ± 0.0021   
  αT-13' 0.0036 ± 0.00072   
  γT 0.59 ± 0.73 δT 0.98 ± 1.07 









Three plasma samples of each treatment group were extracted and analyzed by LC-
MS/MS with MRM mode. Mice were injected AOM at 10 mg/kg body weight and fed 1.5% 
DSS in drinking water. In these mice, the concentration of γT or δT supplemented in 
their diet were very low. Major components in plasma of γT supplemented mice were γ-
CEHC, γT and high amount of αT, which had similar level with the other 2 groups. 9'S 
and 11'S of γT were detected in relatively low concentration but higher than those of 
unconjugated long chain carboxychromanols. 
 
In the plasma of rats supplemented with δT, the concentration of metabolites were very 
low. The major components are sulfated long chain metabolites, αT and δT. Different 
from the previous study when rats were gavaged with single dose of γT or γTE, these 
mice were supplemented with γT or δT at 0.1% in their diet. This concentration is a lot 
lower than the dose gavaged into rats. The metabolism of rats and mice are also 
different. Another factor to consider is that these mice were induced with colon cancer 








Table 3.13 Concentration of Vitamin E Metabolites in Feces of AOM-DSS Colon 
Carcinogenesis Induced Mice Fed with δT at 0.1% Diet or Control Diet 
 






γT-9' 2.09 11.80 
γT-11' 5.70 24.42 
γT-13' 35.50 184.14 
γT-13'-OH 21.31 63.26 
δT-13'S n.d. 32.12 
δT-9' n.d. 61.24 
δT-11' 1.69 220.31 
δT-13' 15.49 1828.63 
δT-13'-OH 25.08 1995.49 
αT-9' 0.97 4.90 
αT-11' 2.98 7.93 
αT-13' 15.41 38.86 
αT-13'-OH 12.56 24.82 
δT n.d. 3659.67 
γT n.d. 0.32 
αT 425.09 433.45 
 
Fecal samples of mice in the control and δT supplemented group of the same study 
were extracted and analyzed by LC-MS/MS analysis in MRM mode. Two samples from 
each group were analyzed. The major components excreted in mice fed with δT diet 
were δT-13' and δT-13'-OH. δT were also excreted at very high concentration. Combined 
with the result of the metabolites in the plasma, in AOM-DSS colon cancer induced mice, 
δT is primarily metabolized to δT-13' and δT-13'-OH which were excreted in high levels 







CHAPTER 4. CONCLUSION AND DISCUSSION 
We have developed a simple and effective extraction method that recovered more than 
90% of different types of vitamin E. This simplified extraction method reduced the 
volume of samples consumed in extraction and also reduced the preparation time. 
 
The optimization of MS/MS parameters using purified sulfated γTE metabolites and 
feces of mice supplemented with δTE-13' improved the sensitivity of detecting vitamin E 
metabolites in biological samples. With the optimized extraction and LC-MS/MS 
acquisition method, we are able to detect all of the vitamin E metabolites in biological 
samples simultaneously. 
 
We observed the 2-double-bond form of δTE-13' as the major metabolite excreted in 
mice fed with the 3-double-bond form of δTE-13. The 2-double-bond metabolite was 
also formed in A549 cells cultured with 3-double-bond form of δTE-13'. Consistent with 
the result in our previous study that in A549 cell cultured medium incubated with γTE at 
20 μM for 48 h, γTE is metabolized to the 2-double-bond form of 13'-
carboxychromanol(31). This suggests that the reduction of the double bond on the C-13 







side chain of tocotrienols might be an important step leading up to the removal of 2-
carbon moiety by β-oxidation. 
 
In the plasma of rats collected 6 h after being gavaged with a single dose of γT at 10, 50 
or 100 mg/kg b.w. or γTE at 10 or 50 mg/kg b.w, the major metabolites were conjugated 
γ-CEHC and sulfated long chain carboxychromanols. This is also consistent with our 
study published in 2009 (31). Interestingly, with the gavaged dose of γT increased from 
10 to 50 mg/kg b.w., the increase of plasma concentration of 9'S, 11'S and sulfated γ-
CEHC was almost proportional. However when the dose was further increased to 100 
mg/kg, only a small increase in plasma concentration of metabolites was observed.  
 
In the plasma of rats collected 6 h after being gavaged with a single dose of γTE at 10 or 
50 mg/kg b.w., we found that the major metabolite, γTE-11'S exists in both 2-double-
bond form and 1-double bond form while γTE-13' also exist in both 2-double-bond and 
3-double-bond form. This result further suggests that LC-MS/MS analysis is a more 
accurate quantification method compared to the HPLC-FL assay which was unable to 
separate the γTE metabolite with only 1 double bond difference in the side chain. The 
discrepancy in quantification of δTE-13' between HPLC-FL assay and LC-MS/MS assay 
has been shown in our study with feces of mice fed with δTE-13'. The overlapping peaks 
in fluorescent chromatogram might cause overestimation of the peak area and 








In feces of AOM-DSS induced mice fed with 0.1% δT or γT diet, δT-13' and δT-13'-OH 
were detected at 1.8 - 2.0 μmol/g in feces of mice supplemented with δT. These results 
suggest that in AOM-DSS induced mice, dietary supplemented δT or γT was substantially 
metabolized. 
 
We attempted to treat plasma samples with overnight incubation with sulfatase/ 
glucuronidase to deconjugate conjugated metabolites in the plasma samples. However, 
the condition that have been proved to convert most of the sulfated long chain γTE 
metabolites in cell cultured medium did not achieve as high desulfation efficacy in 
plasma samples. Previously published study showed that overnight incubation of plasma 
samples with sulfatase at higher concentration achieved complete deconjugation of 
conjugated vitamin E metabolites (44). The reason for the decreased desulfation efficacy 
in plasma sample is not clear at this point. However, by spiking the sulfated long-chain 
carboxychromanol into FBS and comparing the desulfation efficacy of overnight 
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Sample Calculation of Concentration of Isolated γTE-9'S 
 
1) HPLC-UV Quantification of γTE-9' 
UV intensity of converted γTE-9' = 2.62 × 104 
UV intensity of 10 μM (0.2 nmole) of δTE-13' = 2.07 × 104 
Concentration of γTE-9' = 
2.62×104
2.07×104
× 10 μM = 12.64 μM 
2) HPLC-FL Quantification of Desulfation Efficacy of γTE-9'S 
FL intensity of γTE-9'S in the control sample = 8.22 × 106 
FL intensity of γTE-9'S in the sulfatase treated sample = 1.16 × 106 




3) Calculation of Concentration of γTE-9'S 
Concentration of γTE − 9′




= 14.71 μM 
Original concentration is 100 times more concentrated = 14.71 μM × 100 = 1.47 mM 
 
